Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Artificial Intelligence In Cancer Diagnostics Market Value Analysis: What Growth Is Expected Over The Forecast Period?
The market size for artificial intelligence in cancer diagnostics has experienced substantial growth in recent years. It is expected to increase from $0.52 billion in 2025 to $0.69 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 31.3%. The drivers for this historical expansion include the rising volume of medical imaging data, the initial adoption of computer-aided diagnosis, an increase in cancer prevalence, ongoing advancements in imaging technologies, and enhanced healthcare digitization.
The artificial intelligence in cancer diagnostics market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach a value of $2.02 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 30.9%. Factors contributing to this growth during the projection period include the increasing demand for prompt cancer identification, the uptake of precision medicine, enhancements in diagnostic accuracy powered by AI, increased funding for oncology research, and the merging of genomics with imaging data. Key trends anticipated for the forecast timeframe encompass AI-supported medical imaging analysis, the development of more sophisticated early cancer detection instruments, the incorporation of predictive oncology analytics, the streamlining of diagnostic procedures through automation, and the increasing implementation of decision support systems.
Download A Free Sample Report For Comprehensive Market Insights:
Artificial Intelligence In Cancer Diagnostics Market Opportunity Drivers: What Is Creating New Revenue Potential?
The growing incidence of cancer is anticipated to drive the expansion of artificial intelligence within the cancer diagnostics market in the future. Cancer, characterized by unregulated cell proliferation, affects numerous organs and is a major global cause of illness and death. AI finds application in cancer diagnostics, facilitating the precise and effective analysis of medical imagery, thereby assisting in the prompt identification and accurate categorization of malignant growths. As an illustration, in January 2025, data from the American Cancer Society, a non-profit organization based in the US, indicates that the United States is forecast to experience 2,041,910 new cancer diagnoses and 618,120 fatalities from cancer in 2025. Additionally, in February 2024, the World Health Organisation, an intergovernmental body based in Switzerland, reported that roughly 20 million new cancer cases were documented in 2022, resulting in 9.7 million deaths. It was estimated that 53.5 million people were still living five years post-cancer diagnosis. Consequently, the increasing prevalence of cancer is projected to fuel the advancement of artificial intelligence in the cancer diagnostics market.
Artificial Intelligence In Cancer Diagnostics Market Segmentation And Category Breakdown
The artificial intelligence in cancer diagnostics market covered in this report is segmented –
1) By Component: Software Solutions, Hardware, Services
2) By Cancer Type: Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Tumor, Other Types
3) By Application: Screening And Diagnosis, Tumor Identification, Surveillance, Treatment
4) By End-User: Hospitals, Medical Research Institute, Diagnostic Centers, Contract Research Organization
Subsegments:
1) By Software Solutions: Imaging Analysis Software, Predictive Analytics Software, Decision Support Systems, Data Management Platforms
2) By Hardware: Imaging Devices, Biomarkers Detection Equipment, Computing Infrastructure
3) By Services: Consulting Services, Implementation Services, Maintenance And Support Services, Training Services
Artificial Intelligence In Cancer Diagnostics Market Industry Trends Shaping Future Revenue Growth
Major companies in the artificial intelligence in cancer diagnostics market are strategically collaborating to hasten the implementation of AI-driven digital pathology technologies for cancer diagnosis. Strategic partnerships denote a process where companies utilize each other’s strengths and assets to attain reciprocal advantages and achievement. For instance, in October 2023, F. Hoffmann-La Roche AG, a Switzerland-based diagnostics and pharmaceutical company, announced a collaboration with Ibex Medical Analytics, an Israel-based medical technology company, and Amazon Web Services, Inc., a US-based comprehensive and broadly adopted cloud provider. This initiative allows pathology labs to employ the navify Digital Pathology software platform to access Ibex’s AI-powered decision support capabilities, aiding physicians in diagnosing breast and prostate cancer. The joint effort of Ibex Medical Analytics and Roche is creating innovative AI-powered procedures to assist pathologists and laboratories in fully realizing the benefits of going digital. The cloud-based digital pathology and AI solutions from Roche and Ibex are powered by Amazon Web Services (AWS), providing a scalable and sustainable environment for pathology laboratories.
Artificial Intelligence In Cancer Diagnostics Market Competitive Analysis Of Major Industry Participants
Major companies operating in the artificial intelligence in cancer diagnostics market are Microsoft Corporation; Siemens; Roche Holding AG; Google LCC; International Business Machines Corporation; Thermo Fisher Scientific Inc.; Illumina Inc.; Bio Rad Laboratories Inc.; Flatiron Health; Tempus Labs Inc.; Paige AI Inc.; OncoHealth Corporation; Path AI Inc.; Aidoc; Sophia Genetics SA; Digital Diagnostics Inc.; Prognos Health; Aidence; Kheiron Medical Technologies Limited; Zebra Medical Vision; Niramai; Enlitic Inc.; Therapixel; Medial EarlySign Ltd.; Freenome; SkinVision B.V.
Access The Complete Artificial Intelligence In Cancer Diagnostics Market Report:
Artificial Intelligence In Cancer Diagnostics Market Regional Analysis And Leading Geography
North America was the largest region in the artificial intelligence in cancer diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in cancer diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.
